Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Neurology
Disease Category: Diabetic Neuropathy
Trial Information
New investigational medication for Diabetic Peripheral Neuropathy
A randomized, double-blind, placebo- and active-controlled study of the safety and efficacy of RGH-896 in patients with Diabetic Peripheral Neuropathic Pain
This eighteen week study is evaluating the safety and efficacy an investigational medication for patients with Painful Diabetic Peripheral Neuropathy.
Major Inclusion/Exclusion Criteria:
- Ages 18-70
- Type I or Type II Diabetes for at least one year
- Neuropathic pain for at least six months
- Must not have taken Lyrica in the past
- Some medications must be discontinued prior to the study
Alpine Clinical Research Center
1000 Alpine Avenue, Suite 200
Boulder, CO 80304
Phone: 303-443-7229 x109
EMail: Beverly@alpineresearch.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
